Medication Quick Facts
📋Overview
Berotralstat is a medication classified as a plasma kallikrein inhibitor. It functions by blocking the activity of plasma kallikrein, an enzyme that triggers the release of bradykinin in the blood.
By controlling the levels of bradykinin, the medication helps manage the underlying biological processes that lead to excessive swelling. This mechanism is intended to provide a preventive approach to managing hereditary angioedema attacks.
🛡️ Educational information only
This content is provided for general health education and awareness and is based on publicly available medical information. It is not intended to replace professional medical advice, diagnosis, or treatment, and should not be used to make healthcare decisions. Always seek the guidance of a qualified healthcare professional regarding any medical condition, medication, supplement, or procedure.
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
